Biogen (BIIB) Dividends Paid - Common (2009 - 2020)
Biogen (BIIB) posted Dividends Paid - Common of $100000.0 for Q4 2020, down 99.86% on a QoQ basis from $70.9 million in Q3 2020, and down 97.67% year-over-year from $4.3 million in Q1 2020.
Analysis
Biogen (BIIB) Dividends Paid - Common (2009 - 2020) Analysis & Trends
Biogen has reported Dividends Paid - Common for 8 years, with the latest figure at $100000.0 in Q4 2020.
- On a quarterly basis, Dividends Paid - Common fell 97.67% year-over-year to $100000.0 in Q4 2020; TTM through Sep 2021 was $75.3 million, a 0.8% increase from a year earlier, with the FY2020 full-year figure at $71.0 million, changed N/A from the prior year.
- Dividends Paid - Common was $100000.0 for Q4 2020 at Biogen, down from $70.9 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $302.7 million in Q1 2017, with the low at -$2.0 million in Q3 2018.
- Average Dividends Paid - Common over 4 years is $60.8 million, with a median of $4.3 million recorded in 2019.
- The sharpest annual moves came in 2019 and 2020: Dividends Paid - Common jumped 960.0% in 2019, then sank 97.67% in 2020.
- Over 4 years, Dividends Paid - Common stood at $302.7 million in 2017, then plunged by 100.17% to -$500000.0 in 2018, then surged by 960.0% to $4.3 million in 2019, then tumbled by 97.67% to $100000.0 in 2020.
- The last three Dividends Paid - Common figures came in at $100000.0 (Q4 2020), $70.9 million (Q3 2020), and $4.3 million (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 1.36 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 1.03 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 96.80 Mn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | - |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 70.90 Mn |
| Dec 31, 2019 | 4.30 Mn |
| Dec 31, 2018 | -500,000.00 |
| Sep 30, 2018 | -2.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Mar 31, 2017 | 302.70 Mn |
| Sep 30, 2015 | 60.00 Mn |
| Dec 31, 2011 | 2.95 Mn |
| Sep 30, 2011 | 14.18 Mn |
| Dec 31, 2010 | 17.07 Mn |
| Sep 30, 2010 | 8.59 Mn |
| Jun 30, 2010 | -1.43 Mn |
| Mar 31, 2010 | -760,000.00 |
| Dec 31, 2009 | -7.19 Mn |